Kopran Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kopran Limited with three other
companies in this sector in INDIA :
Sms Pharmaceuticals Limited
sales of 4.12 billion Indian Rupees [US$55.90 million]
of which 100%
was ents and Intermediates),
RPG Life Sciences Limited
(3.76 billion Indian Rupees [US$50.96 million]
Albert David Limited
(3.20 billion Indian Rupees [US$43.41 million]
of which 100%
was manufacturing of pharmaceuticals).
During the year ended March of 2020, sales at
Kopran Limited were 3.59 billion Indian Rupees (US$48.78 million).
a very small
increase of 0.4%
versus 2019, when the company's sales were 3.58 billion Indian Rupees .
This was the fourth straight year of sales growth at Kopran Limited.
Sales of Bulk Drugs saw an increase
that was more than double the company's growth rate: sales were up
6.2% in 2020, from
1.73 billion Indian Rupees to 1.84 billion Indian Rupees .
Not all segments of Kopran Limited experienced an increase in sales in 2020:
sales of Other fell 56.5% to 18.53 million Indian Rupees .
(However, this segment's sales were only a very small portion of the company's overall sales).
Kopran Limited also experienced decreases in sales in
Tablet (down 4.1% to 1.65 billion Indian Rupees )